Related Experiment Video
Updated: Feb 16, 2026
09:46
Training Persons with Spinal Cord Injury to Ambulate Using a Powered Exoskeleton
Published on: June 16, 2016
21.5K
[The Cell Therapy in Traumatic Spinal Cord Injury]
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|January 4, 2018
Summary
Olfactory mucosa cells show promise for treating traumatic spinal cord injury by aiding motor and sensory function recovery. This cell therapy offers a safe, feasible, and effective approach for patients.
Area of Science:
- Regenerative Medicine
- Neuroscience
- Cell Biology
Background:
- Traumatic spinal cord injury (SCI) presents significant challenges in motor and sensory function recovery.
- Various cell types, including stem cells and Schwann cells, have been investigated for SCI treatment with mixed results.
- Methodological and ethical concerns, alongside variable efficacy and side effects, complicate optimal cell therapy selection for SCI.
Purpose of the Study:
- To review the potential of cellular therapies for traumatic spinal cord injury.
- To identify the most promising cell types for SCI treatment.
- To evaluate the safety, efficacy, and feasibility of olfactory mucosa cells for SCI.
Main Methods:
- Comprehensive review of experimental and clinical studies on cell-based therapies for SCI.
- Analysis of different cell types: embryonic stem cells, induced pluripotent stem cells, mesenchymal stem cells, Schwann cells, and olfactory mucosa cells.
- Evaluation of therapeutic effects, including motor and sensory function recovery, remyelination, and axonal regeneration.
Main Results:
- Cellular therapies have demonstrated positive therapeutic effects in SCI, including motor and sensory function recovery.
- Olfactory mucosa cells emerge as a highly promising option due to their safety, feasibility, and efficacy.
- Autologous olfactory mucosa cells facilitate remyelination and axonal regeneration, leading to improved motor function post-SCI.
Conclusions:
- Olfactory mucosa cells offer a tissue-specific and autologous approach for SCI cell therapy.
- The procedure for obtaining olfactory mucosa is safe and feasible for patients.
- Olfactory mucosa cells hold significant potential for clinical application in treating traumatic spinal cord injury.
Related Concept Videos
01:26Spinal Cord
2.0K
The spinal cord, a critical component of the central nervous system, extends from the base of the brainstem to the lumbar region of the vertebral column. It is essential for maintaining physical stability and facilitating communication between the brain and peripheral parts of the body.
2.0K
01:54The Spinal Cord
32.0K
The spinal cord is the body’s major nerve tract of the central nervous system, communicating afferent sensory information from the periphery to the brain and efferent motor information from the brain to the body. The human spinal cord extends from the hole at the base of the skull, or foramen magnum, to the level of the first or second lumbar vertebra.
32.0K
01:10Spinal Cord: Information Processing
3.7K
The spinal cord is an integral hub for motor and sensory information that enables the brain to communicate with the peripheral nervous system (PNS). This communication consists of relaying sensory data and transmission of motor commands.
Sensory Information Processing
Sensory information processing begins at the sensory receptors located in the skin and other tissues, which detect somatic sensory stimuli such as touch, temperature, or pain. These receptors function as catalysts, initiating...
Sensory Information Processing
Sensory information processing begins at the sensory receptors located in the skin and other tissues, which detect somatic sensory stimuli such as touch, temperature, or pain. These receptors function as catalysts, initiating...
3.7K
01:15Spinal Cord: Gross Anatomy
6.0K
The spinal cord resides within the protective confines of the vertebral column. It is the main pathway for information traveling between the brain and the body. It plays a fundamental role in nearly all bodily functions, from simple reflexes to complex motor movements. The spinal cord begins at the medulla oblongata at the base of the brainstem and extends downward, terminating at the conus medullaris near the first and second lumbar vertebrae. The spinal cord's length in adults is...
6.0K
01:16Spinal Cord: Cross-sectional Anatomy
5.0K
The cross-sectional anatomy of the spinal cord offers a detailed view of its complex structure and function within the central nervous system. At the core of the spinal cord lies the gray matter, characterized by its butterfly or "H"-shaped appearance in cross-section. This central region is enveloped by white matter, with the overall structure divided into symmetrical halves by the dorsal median sulcus and the ventral median fissure.
Gray Matter and its Components
Central to the gray matter is...
Gray Matter and its Components
Central to the gray matter is...
5.0K
00:59Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K